Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Nov 11, 2020 9:39pm
128 Views
Post# 31882590

RE:RE:RE:Let's analyse if 1 + 1 = 2 ??

RE:RE:RE:Let's analyse if 1 + 1 = 2 ??Your statement makes no sense, why can't Corvax be a stand alone vaccine ??? What properties of the compound would be desired to mix with someone else's vaccine candidate...... please elaborate cause this is the first I've heard of this concept
Charleyfarley wrote:
I have been made aware that USAMRIID are testing the vaxil mix to use in enhancing other Vaccines . My source is reliable. Much like CBD and lets say Naproxin mixed together that create the correct Pain drops if you can relate --so theres your 1 =1 = 2. Vaxil will never have their own vaccine. They will compliment other vaccines. The non-brokered PP is for expenses that are occurring rapidly . Once the Data is analysed (I feel it already has) then Money will flow like a river. I am expecting a Rapid PP close with Inside participaction and news to follow.....The six week timeline is accurate .


<< Previous
Bullboard Posts
Next >>